Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Melanie A. Thompson, MD

Principal Investigator
AIDS Research Consortium of Atlanta
Atlanta, GA, United States

Dr. Melanie Thompson has been caring for persons living with HIV since 1982. As Principal Investigator of the AIDS Research Consortium of Atlanta beginning in 1988, she has conducted over 400 studies in the areas of HIV treatment, prevention, diagnostics and epidemiology, as well as HCV and STI diagnostics and treatment. She currently serves on the HHS Antiretroviral Guidelines panel and the International Antiviral Society-USA Antiretroviral Guidelines panel. She is Past Chair of the HIV Medicine Association (HIVMA) and serves on its Ryan White Medical Providers Steering Committee and the HIVMA Ending the HIV Epidemic Working Group . She is co-chair of the HIVMA/IDSA HIV Primary Care Guidance Panel whose recommendations were recently published in Clinical Infectious Diseases. She was Executive Editor of the Strategy to End AIDS in Fulton County, published in 2017, and served on its HIV/AIDS Advisory Committee. She serves on the Georgia Department of Public Health's HIV Medical Advisory Committee and its Legal and Ethical Advisory Committee. Her passion is to contribute to the end of the domestic HIV epidemic, especially in the South, through treatment, prevention, policy, and the ongoing fight against structural racism, stigma, and discrimination.

Cepheid, Inc (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Cytodyn, Inc (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Frontier Biotechnologies (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Gilead Sciences (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; GlaxoSmithKline (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; Merck Sharp Dohme (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support; ViiV Healthcare (Individual(s) Involved: Self): Fees for conduct of clinical trials paid to AIDS Research Consortium of Atlanta, Research Grant or Support

Presentation(s):